DR CHOUCHANE
ActiveSummary
DR CHOUCHANE has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €126,090 and a net result of €115,212. Equity is growing by about 7.3% per year across the filed financial years. Its solvency ranks better than 47% of 20,614 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
26-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 26 days late
2025
31-12
Financial
Highest result from 2018 to 2025net €115,212 ▲9.6%
Operating result €158,206, net result €115,212, both a record.
31-12
Financial
Equity above €100,000equity €126,090 ▲38.7%
A profit in every financial year since 2018 builds equity to €126,090.
30-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
14-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 14 days late
2023
26-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
05-08
NBB filing
Annual accounts filed
financial year 2021 · micro format · 5 days late
2021
31-12
Financial
Weakest financial yearnet €6,844 ▼38.2%
Net result drops to €6,844, the lowest in the series; recovery starts the following year.
23-08
NBB filing
Annual accounts filed
financial year 2020 · micro format · 23 days late
2020
24-08
NBB filing
Annual accounts filed
financial year 2019 · micro format · 24 days late
2019
26-08
NBB filing
Annual accounts filed
financial year 2018 · micro format · 26 days late
2018
28-06
NBB filing
Annual accounts filed
financial year 2017 · micro format
2017
17-08
NBB filing
Annual accounts filed
financial year 2016 · micro format · 17 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.